Articles by : Rich Daly, Editor in Chief

Two 340B Terminations, One Payback to Manufacturers in Latest Provider Audit Findings

February 1, 2024 Rich Daly, Editor in Chief Views

Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of two more 340B providers.

Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AIDS Group Holds Protest Against NACHC-PhRMA Partnership

February 1, 2024 Rich Daly, Editor in Chief Views

The AIDS Healthcare Foundation staged a protest over ASAP 340B, an alliance between community health centers and the drug industry, at the 340B Coalition Winter Conference.

As many attendees gathered for lunch outside at the 340B Coalition Winter Conference in San Diego on Tuesday, the AIDS [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospital Critics Ramp Up Efforts on Capitol Hill and in Media

February 1, 2024 Rich Daly, Editor in Chief Views

ASAP 340B is one of multiple critics of hospital participation in 340B to recently increase lobbying and media efforts, including an online advertising campaign pictured above.

Critics of hospital participation in the 340B discount drug program are ramping up efforts, as a bipartisan group of senators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Former Sen. Cassidy Aide, Trump Administration Executive Criticizes Requiring More Hospital 340B Reporting

January 30, 2024 Rich Daly, Editor in Chief Views

Brenda Destro, a former aide to a Republican senator and HHS official, recently wrote an op-ed that criticized hospital 340B transparency legislation.

A former Trump administration Health and Human Service Department (HHS) executive and adviser to Sen. Bill Cassidy (R-LA) published a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

January 30, 2024 Rich Daly, Editor in Chief Views

Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.

The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospitals Had Largest Markups of High-Cost Infused Drugs: Study

January 30, 2024 Rich Daly, Editor in Chief Views

A New England Journal of Medicine study found that 340B hospitals had larger price markups than other hospitals or physician practices for certain high-cost infusion drugs.

340B hospitals had larger price markups than other hospitals or physician practices for 57 high-cost infusion drugs, according to a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK, Vertex Offer Refunds to 340B Providers

January 30, 2024 Rich Daly, Editor in Chief Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genesis CEO Praises Court Decision, Blasts HRSA, NACHC, State Primary Care Association

January 25, 2024 Rich Daly, Editor in Chief Views

Tony Megna, CEO and general counsel of Genesis Healthcare, shared his first public comments with 340B Report on a key 340B court decision.

In his first public comments since a key federal court decision on the 340B patient definition, the leader of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Looks to Amend Temporary Contract Pharmacy Agreement with Novo Nordisk

January 25, 2024 Rich Daly, Editor in Chief Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

After hospitals in Arkansas raised concerns over details of an agreement by Novo Nordisk to temporarily loosen contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provider-Drugmaker Lobbying Group Adds Two More Manufacturers

January 23, 2024 Rich Daly, Editor in Chief Views

340B Working Table's lobbying disclosure filing.

A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live